about
Management of peptic ulcer disease not related to HelicobacterIs ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studiesPersonal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?Adaptation of the stomach to injury from nonsteroidal anti-inflammatory drugs.Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitisCOX-2 inhibition versus gastroprotection with dual COX inhibitors: an evidence-based approach.Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugsConsensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.Anti-Tumour Necrosis Factor α Therapies and Inflammatory Bowel Disease Pregnancy Outcomes: A Meta-analysis.Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH.Gastric mucosal defensive factors: the therapeutic strategy.Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium.Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.Aspirin: old drug, new uses and challenges.Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.Health care in late Qing Dynasty and Republican China: Western influences, Chinese solutions.Oral human spasmolytic polypeptide protects against aspirin-induced gastric injury in rats.Students coached for an admission test perform less well throughout a medical course.Pericanalicular location of hepatocyte lysosomes and effects of fasting: a morphometric analysis.Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.Helicobacter pylori increases the risk of low-dose aspirin ulcers: A meta-analysisAugmented gp130-mediated cytokine signalling accompanies human gastric cancer progressionMorning or Evening Dosing with Low-Dose Omeprazole: Effects on 24-Hour Gastric Acidity Profiles in Duodenal Ulcer PatientsLetter: Gastrotoxic effect of parenteral aspirinDouble-blind controlled trial of ranitidine versus cimetidine in the treatment of duodenal ulcerationElectron microscopic study of the repair of aspirin-induced gastric erosionsEpithelial cell proliferation and migration in the developing rat gastric mucosaCampylobacter pylori--gastroduodenal pathogen or opportunistic bystander?Ageing has no effect on the volume density of hepatocytes, reticulo-endothelial cells or the extracellular space in livers of female Sprague-Dawley ratsThe Mallory-Weiss syndromeEarly endoscopy in haematemesis and melaenaEthanol-induced cell damage in cultured rat antral mucosa assessed by chromium-51 releaseEthanol impairs biliary lysosomal enzyme release in ratsRelapse of duodenal ulcers after cimetidine treatment: idol 'indecently' assaulted?Lack of effect of omeprazole, a potent inhibitor of gastric (H+ + K+) ATPase, on hepatic lysosomal integrity and enzyme activityOmeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosageAbsence of histopathological response to cadmium in gill and digestive diverticula of the mussel, Mytilus edulis
P50
Q28192901-5F177764-A93A-454E-883A-6B0C10458606Q28201393-B927DB2B-80B0-42F1-A482-1CD9D820A64FQ28221704-DA5E488E-12A6-4DDD-ABEF-10F4D6F86F08Q33874484-86AF0C70-7B3A-4D5E-897A-09AAF56ED523Q34140801-8F876227-4C51-4289-90CE-2279DE3A535FQ34459461-E7B10391-16B7-4EF7-86E0-F67069B3E1B3Q35355069-0F05BF76-0783-4B57-9AA7-E0B328C976A7Q35551920-F6FB872C-89EA-4A1B-9527-AB75C3F6BBA2Q35594966-4551AAC4-99DB-489E-AEB9-CD6441B5F2CBQ35598707-70D93071-ACDF-48E5-9166-2C1E3E46B09BQ38537853-F378B3E2-1EC1-4E20-8920-26B2AF46A0D5Q38693018-29E73AB6-5609-4662-91DA-14768551AD81Q39425872-1EF16101-A24E-416B-831F-1B366E1789EAQ40606920-59DFA711-7A2C-41C3-9383-1388BE78FA03Q42503038-35CDC867-F8C5-4157-9B9A-A8FFA4858CEFQ42634860-4F036987-6C88-405B-ADE0-87AB0D3B1801Q45013631-F05D3EC8-F744-4940-9DCF-40306F1EE052Q46957598-820DA31D-B2EC-47A4-9FA2-23944C63201CQ47251261-A9ACDB78-5D11-4AA6-A2DD-9CC22435F3F6Q47925476-FEC7AAEF-E813-4435-BE01-F10F758E96FBQ50747535-4D6ECAFE-36D9-43D6-B3E3-F855DF511B2DQ51634421-10328A5A-AA70-49F4-A021-67C5BB7309A5Q52581418-5657E1FF-E1E6-456A-B5A3-17F5DB40DE8BQ58583314-4ED829D7-A3D9-486E-ACC2-EE46DE180CF2Q62002227-0939DF91-00D5-4876-B447-D7336754DAFAQ62899737-58F74157-D251-4C0F-A10A-1291443C2CBBQ66887338-976884A8-E2E2-4C4C-A930-0B13AE9E5522Q67253302-0B204A5B-8849-4FA9-B47B-CD6394D9D412Q67763393-AFF632FA-13F4-483B-BEA9-4E97DA4144F2Q67864914-25BE5A1B-5CBA-4BD2-8DC6-E60A64805039Q67976707-CCAD11DC-5708-444D-86AC-A88F3AE4924BQ68010701-0F0BFD58-BCFF-4E7A-8108-C2B74D78AFB2Q69126377-29BEE6F0-C023-48B2-995B-EE8B073029EDQ69550959-3DC34C85-E835-4C5D-AC29-AB32BACA9688Q69567807-0008212E-C1BC-4A3D-B84B-C394BFB6DC3AQ69718293-1DC56373-D5EB-479E-A668-EE3A3F552527Q69848101-5EDBCD3C-5958-48D4-998A-F3767A5275FDQ69879079-4D656265-A754-4185-A65A-C012413D7B0DQ69880549-35CFB6E5-233C-4A4B-9EAD-295D800BB79EQ69989228-013F42D0-B0C1-481E-976E-6CE8BFD9BE21
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Neville D Yeomans
@ast
Neville D Yeomans
@en
Neville D Yeomans
@es
Neville D Yeomans
@nl
Neville D Yeomans
@sl
type
label
Neville D Yeomans
@ast
Neville D Yeomans
@en
Neville D Yeomans
@es
Neville D Yeomans
@nl
Neville D Yeomans
@sl
prefLabel
Neville D Yeomans
@ast
Neville D Yeomans
@en
Neville D Yeomans
@es
Neville D Yeomans
@nl
Neville D Yeomans
@sl
P106
P108
P31
P496
0000-0001-9870-832X